临床牙周病学：药物性牙龈增生的治疗专辑

目录Contents

经典文献 Classic Literatures

从药物性牙龈增生患者三维坐标数据分析牙龈形态

的改变……………………………………………… 1

Analysis of changes in gingival contour from threedimensional

co-ordinate data in subjects with drug-induced

gingival overgrowth

Thomason JM, Ellis JS, Jovanovski V, Corson M, Lynch E,

Seymour RA

栾庆先 审 张井然 译

苯妥英诱导的牙龈增生的影响因素………………… 6

Factors influencing phenytoin-induced gingival

enlargement

Majola MP, McFadyen ML, Connolly C, Nair YP, Govender M

章锦才 审 董潇潇 译

药物性牙龈增生的风险因素……………………… 13

Risk factors for drug-induced gingival overgrowth

Seymour RA, Ellis JS, Thomason JM

章锦才 审 万鹏 译

牙周疾病患者使用钙离子通道拮抗剂引起牙龈增生

的处理、处方用药、治疗反应以及额外花费…… 17

Management of periodontal disease in patients using

calcium channel blockers – gingival overgrowth, prescribed

medications, treatment responses and added treatment costs

Fardal Ø, Lygre H

栾庆先 审 曾佳骏 译

牙周治疗对于环孢素A诱导的牙龈增生严重程度的

有效性………………………………………………… 22

Effectiveness of periodontal therapy on the severity of

cyclosporin A-induced gingival overgrowth

Aimetti M, Romano F, Debernardi C

章锦才 审 董潇潇 译

钙离子通道拮抗剂与牙龈增生的相互关系………… 27

Association between calcium channel blockers and gingival

hyperplasia

Kaur G, Verhamme KMC, Dieleman JP, Vanrolleghem A, van

Soest EM, Stricker BHCh, Sturkenboom MCJM

栾庆先 审 王延峰 译

摘要 Abstracts

接受硝苯地平和地尔硫治疗的患者在对因牙周治

疗后牙龈和牙周情况的评估*… …………………… 32

Evaluation of gingival and periodontal conditions

following causal periodontal treatment in patients treated

with nifedipine and diltiazem*

BuHon P. Machuca G. Martinez-SahuquiUo A. Rios JV. Velasco E.

Rojas J. LacaJle JR

章锦才 审 董潇潇 译

3种不同手术方法治疗药物性牙龈增生的疗效观察… 32

The efficacy of three different surgical techniques in the

management of drug-induced gingival overgrowth

Mavrogiannis M, Ellis JS, Seymour RA, Thomason JM

章锦才 审 董潇潇 译

各种药物对接受多种药物治疗的成年和少年肾移植

患者牙龈增生的分别影响………………………… 33

Contribution of individual drugs to gingival overgrowth

in adult and juvenile renal transplant patients treated with

multiple therapy

Wilson RF, Morel A, Smith D, Koffman CG, Ogg CS, Rigden SPA,

Ashley FP

章锦才 审 董潇潇 译

接受地尔硫或维拉帕米治疗患者的牙龈增生患病

率和风险…………………………………………… 33

Prevalence and risk of gingival overgrowth in patients

treated with diltiazem or verapamil

Miranda J, Brunet L, Roset P, Berini L, FarréM, Mendieta C

章锦才 审 董潇潇 译

硝苯地平引起牙龈增生的发生率和严重程度……… 34

The incidence and severity of nifedipine-induced gingival

overgrowth

Barclay S, Thomason JM, Idle JR and Seymour RA

栾庆先 审 李雪 译

评估环孢素A引起牙龈增生的住院患者中HLA决定

簇的分布频率……………………………………… 34

Evaluation of the frequency of HLA determinants in patients

with gingival overgrowth induced by cyclosporine-A

Ceheci I, Kamarci A, Firatli E, Aygun S, Tanyeri H, Aydin AE,

Çarin M. Güç U, Tuncer Ö

栾庆先 审 李雪 译

影响器官移植患者牙龈增生程度的危险因素评估

HLA表型的作用……………………………………… 35

Determinants of gingival overgrowth severity in organ

transplant patients An examination of the role of HLA

phenotype

Thomason JM. Seymour R.4. Ellis JS. Kelly PJ. Parry G. Dark J.

Wilkin.son R, Ilde JR

栾庆先 审 李雪 译

移植前牙龈增生可预测环孢素引起肾移植患者牙龈

严重增生……………………………………………… 35

Pre-transplant gingival hyperplasia predicts severe

cyclosporin-induced gingival overgrowth in renal

transplant patients

Varga E. Lennon MA, Mair LH

栾庆先 审 李雪 译

药物性牙龈增生：一项对法国药物警戒数据库的研究… 36

Drug-induced gingival overgrowth: a study in the French

Pharmacovigilance Database

Bondon-Guitton E, Bagheri H, Montastruc J-L

章锦才 审 万鹏 译

肾移植术后服用环孢素A的患者的IL-1A基因多态性与

牙龈增生的关系……………………………………… 36

Relationship between IL-1A polymorphisms and gingival

overgrowth in renal transplant recipients receiving Cyclosporin A

Bostanci N, Ilgenli T, Pirhan DC, Clarke FM, Marcenes W, Atilla

G, Hughes FJ, McKay IJ

章锦才 审 万鹏 译

叶酸对苯妥英性牙龈增生的作用………………… 37

Effect of folate on phenytoin hyperplasia

Drew HJ. Vogel RI. Mohfsky W. Baker H and Frank O

章锦才 审 万鹏 译

器官移植后应用免疫抑制剂他克莫司的患者牙龈增

生的患病率…………………………………………… 37

Prevalence of gingival overgrowth in transplant patients

immunosuppressed with tacrolimus

Ellis JS, Seymour RA, Taylor JJ, Thomason JM

章锦才 审 万鹏 译